Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
Francesco Castelli1, *, Virginio Pietra2, Ismael Diallo3, Richard F. Schumacher4, Jacques Simpore5
Identifiers and Pagination:Year: 2010
First Page: 28
Last Page: 32
Publisher Id: TOAIDJ-4-28
Article History:Received Date: 29/4/2009
Revision Received Date: 5/5/2009
Acceptance Date: 1/7/2009
Electronic publication date: 19/1/2010
Collection year: 2010
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individual, (●) stigma, (●) lack of qualified human resources and infrastructure, especially in the rural setting, (●) rescue drugs for failing patients and (●) pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along.